The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study
Objective. To explore the impact of radiation dose on preoperative neoadjuvant chemoradiotherapy effects for patients with locally advanced squamous cell esophageal carcinoma (LASCEC) with long-term follow-up data. Methods. The patients with LASCEC received either low dose radiotherapy (50.4Gy/23f/1...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/7581799 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832562413244776448 |
---|---|
author | Yanru Mu Hui Wang Tao He Li Xu |
author_facet | Yanru Mu Hui Wang Tao He Li Xu |
author_sort | Yanru Mu |
collection | DOAJ |
description | Objective. To explore the impact of radiation dose on preoperative neoadjuvant chemoradiotherapy effects for patients with locally advanced squamous cell esophageal carcinoma (LASCEC) with long-term follow-up data. Methods. The patients with LASCEC received either low dose radiotherapy (50.4Gy/23f/1.8Gy) or a high dose (64.8Gy/25f/1.8Gy) followed by neoadjuvant chemotherapy preoperatively were included in this study. To balance potential bias, 1 : 1 propensity score matching (PSM) with a caliper of 0.1 was used. The two groups were compared in terms of radical resection, post-radiation adverse event rates, perioperative mortality, postoperative adverse event rates, overall survival (OS), local recurrence rate, and distant metastatic rate. Results. Forty-two patients were enrolled in this study, with 21 patients in each group after PSM. There was no difference in baseline characteristics between the two groups (all p >0.05). The rates of radical resection (71.4% vs 57.1%, P =0.334), perioperative mortality (9.5% vs 4.8%, P =0.549), and postoperative adverse event rates (76.2% vs 90.5%, P =0.410) did not differ significantly between the two groups. The 5-year OS rate was statistically higher in the group with a high dose (66.7% vs. 28.6%, P =0.013). Meanwhile, the local recurrence rate was statistically lower in the high dose group (14.3% vs 47.6%, P =0.019 for 3 years; 33.3% vs 66.6%, P =0.031 for 5 years). Moreover, the 3-year distant metastasis rate was statistically lower in the group with a high dose (9.5% vs 38.1%, P = 0.03). Conclusion. Patients with LASCEC may benefit from preoperative neoadjuvant chemoradiotherapy with a high radiation dosage (64.8Gy/25f/1.8Gy). |
format | Article |
id | doaj-art-78fb33817b8441b1bded079cfcb54e75 |
institution | Kabale University |
issn | 2314-7156 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-78fb33817b8441b1bded079cfcb54e752025-02-03T01:22:41ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7581799The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective StudyYanru Mu0Hui Wang1Tao He2Li Xu3Department of RadiotherapyDepartment of RadiotherapyDepartment of RadiotherapyDepartment of RadiotherapyObjective. To explore the impact of radiation dose on preoperative neoadjuvant chemoradiotherapy effects for patients with locally advanced squamous cell esophageal carcinoma (LASCEC) with long-term follow-up data. Methods. The patients with LASCEC received either low dose radiotherapy (50.4Gy/23f/1.8Gy) or a high dose (64.8Gy/25f/1.8Gy) followed by neoadjuvant chemotherapy preoperatively were included in this study. To balance potential bias, 1 : 1 propensity score matching (PSM) with a caliper of 0.1 was used. The two groups were compared in terms of radical resection, post-radiation adverse event rates, perioperative mortality, postoperative adverse event rates, overall survival (OS), local recurrence rate, and distant metastatic rate. Results. Forty-two patients were enrolled in this study, with 21 patients in each group after PSM. There was no difference in baseline characteristics between the two groups (all p >0.05). The rates of radical resection (71.4% vs 57.1%, P =0.334), perioperative mortality (9.5% vs 4.8%, P =0.549), and postoperative adverse event rates (76.2% vs 90.5%, P =0.410) did not differ significantly between the two groups. The 5-year OS rate was statistically higher in the group with a high dose (66.7% vs. 28.6%, P =0.013). Meanwhile, the local recurrence rate was statistically lower in the high dose group (14.3% vs 47.6%, P =0.019 for 3 years; 33.3% vs 66.6%, P =0.031 for 5 years). Moreover, the 3-year distant metastasis rate was statistically lower in the group with a high dose (9.5% vs 38.1%, P = 0.03). Conclusion. Patients with LASCEC may benefit from preoperative neoadjuvant chemoradiotherapy with a high radiation dosage (64.8Gy/25f/1.8Gy).http://dx.doi.org/10.1155/2022/7581799 |
spellingShingle | Yanru Mu Hui Wang Tao He Li Xu The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study Journal of Immunology Research |
title | The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study |
title_full | The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study |
title_fullStr | The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study |
title_full_unstemmed | The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study |
title_short | The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study |
title_sort | impact of radiation dose on preoperative neoadjuvant chemoradiotherapy effects for patients with locally advanced squamous cell esophageal carcinoma a propensity score matched retrospective study |
url | http://dx.doi.org/10.1155/2022/7581799 |
work_keys_str_mv | AT yanrumu theimpactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT huiwang theimpactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT taohe theimpactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT lixu theimpactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT yanrumu impactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT huiwang impactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT taohe impactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy AT lixu impactofradiationdoseonpreoperativeneoadjuvantchemoradiotherapyeffectsforpatientswithlocallyadvancedsquamouscellesophagealcarcinomaapropensityscorematchedretrospectivestudy |